Divi’s Laboratories reports 13% rise in Q1 consolidated net profit

09 Aug 2021 Evaluate

Divi’s Laboratories has reported results for first quarter ended June 30, 2021.

The company has reported a rise of 12.13% in its net profit at Rs 551.97 crore for the quarter under review as compared to net profit of Rs 492.25 crore for the same quarter in the previous year. Total income of the company increased by 14.93% at Rs 1985.71 crore for Q1FY22 as compared Rs 1727.83 crore for the corresponding quarter previous year.

On the consolidated basis, the company has reported a rise of 13.22% in its net profit attributed to shareholders at Rs 557.11 crore for the quarter under review as compared to Rs 492.06 crore for the same quarter in the previous year. Total income of the company increased by 14.24% at Rs 1996.61 crore for Q1FY22 as compared Rs 1747.80 crore for the corresponding quarter previous year.

Divis Lab Share Price

6342.60 -52.05 (-0.81%)
01-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1720.40
Dr. Reddys Lab 1253.60
Cipla 1500.10
Zydus Lifesciences 914.50
Lupin 2103.30
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×